CH546769A - Procede pour la preparation de nouveaux composes chimiques. - Google Patents

Procede pour la preparation de nouveaux composes chimiques.

Info

Publication number
CH546769A
CH546769A CH903672A CH546769DA CH546769A CH 546769 A CH546769 A CH 546769A CH 903672 A CH903672 A CH 903672A CH 546769D A CH546769D A CH 546769DA CH 546769 A CH546769 A CH 546769A
Authority
CH
Switzerland
Prior art keywords
preparation
chemical compounds
new chemical
new
compounds
Prior art date
Application number
CH903672A
Other languages
English (en)
French (fr)
Original Assignee
Experimentales Et Cliniques De
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Experimentales Et Cliniques De filed Critical Experimentales Et Cliniques De
Publication of CH546769A publication Critical patent/CH546769A/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D237/10—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D237/20—Nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
CH903672A 1971-06-18 1972-06-16 Procede pour la preparation de nouveaux composes chimiques. CH546769A (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB2873771 1971-06-18
FR7219096A FR2141697B1 (OSRAM) 1971-06-18 1972-05-29

Publications (1)

Publication Number Publication Date
CH546769A true CH546769A (fr) 1974-03-15

Family

ID=26217112

Family Applications (1)

Application Number Title Priority Date Filing Date
CH903672A CH546769A (fr) 1971-06-18 1972-06-16 Procede pour la preparation de nouveaux composes chimiques.

Country Status (13)

Country Link
US (1) US4169158A (OSRAM)
JP (1) JPS5550943B1 (OSRAM)
AR (1) AR192370A1 (OSRAM)
AU (1) AU472247B2 (OSRAM)
BE (1) BE784727A (OSRAM)
CA (1) CA1003833A (OSRAM)
CH (1) CH546769A (OSRAM)
DE (1) DE2229215C2 (OSRAM)
ES (1) ES403998A1 (OSRAM)
FR (1) FR2141697B1 (OSRAM)
GB (1) GB1345880A (OSRAM)
NL (1) NL177893C (OSRAM)
SE (1) SE392899B (OSRAM)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2510998B1 (fr) * 1981-08-07 1986-01-10 Sanofi Sa Nouveaux derives amines de la pyridazine, leur procede de preparation et les medicaments, a action desinhibitrice, qui en comportent
FR2510997A1 (fr) * 1981-08-10 1983-02-11 Sanofi Sa Nouveaux derives de la methyl-4 phenyl-6 pyridazine, procede pour leur preparation et medicaments actifs sur le systeme nerveux central en contenant
FR2511366A1 (fr) * 1981-08-11 1983-02-18 Sanofi Sa Nouveaux derives de la pyridazine, leur procede de preparation et les medicaments, actifs sur le systeme nerveux central, qui en contiennent
FR2539741A1 (fr) * 1983-01-21 1984-07-27 Sanofi Sa Composes a noyau heterocyclique diazote, leur procede de preparation et les medicaments, actifs sur le systeme nerveux central, qui en contiennent
FR2539739B1 (fr) * 1983-01-24 1985-11-22 Sanofi Sa Nouveaux derives de la naphtyl pyridazine actifs sur le systeme nerveux central, procede de preparation de ces derives et medicaments en contenant
FR2539742B1 (fr) * 1983-01-24 1986-09-05 Sanofi Sa Derives amines de la pyridazine substitues en position 6 par un heterocycle ou un alicycle, lesdits derives etant actifs sur le systeme nerveux central
US4565814A (en) * 1983-01-28 1986-01-21 Sanofi Pyridazine derivatives having a psychotropic action and compositions
FR2540115B1 (fr) * 1983-01-28 1985-06-07 Sanofi Sa Derive de la pyridazine ayant une action psychotrope, son mode de preparation et les medicaments en contenant
FR2555178B1 (fr) * 1983-11-18 1986-04-18 Sanofi Sa Derives cyanes de la pyridazine ayant une action psychotrope, leur mode de preparation et les medicaments en contenant
FR2625201B1 (fr) * 1987-12-24 1990-06-15 Sanofi Sa Nouveaux derives tricycliques agonistes des recepteurs cholinergiques et medicaments en contenant
FR2642757B1 (fr) * 1989-02-07 1991-05-24 Sanofi Sa Nouveaux derives de la pyridazine, procede de preparation et compositions pharmaceutiques en contenant
FR2642648B1 (fr) * 1989-02-07 1991-06-21 Sanofi Sa Utilisation de derives d'alkyl-5 pyridazine comme medicaments actifs sur le systeme cholinergique
PT93060B (pt) 1989-02-07 1995-12-29 Sanofi Sa Processo para a obtencao de derivados de piridazina e de composicoes farmaceuticas que os contem
FR2642754B1 (fr) * 1989-02-07 1991-05-24 Sanofi Sa Nouveaux derives de la pyridazine, procede de preparation et compositions pharmaceutiques en contenant
US5461053A (en) * 1989-02-07 1995-10-24 Sanofi Pyridazine derivatives
US20100210590A1 (en) * 1995-09-27 2010-08-19 Northwestern University Compositions and treatments for seizure-related disorders
US20030176437A1 (en) 2001-08-31 2003-09-18 D.M. Watterson Anti-inflammatory and protein kinase inhibitor compositions and related methods for downregulation of detrimental cellular responses and inhibition of cell death
WO2006050359A2 (en) 2004-11-02 2006-05-11 Northwestern University Pyridazine compounds and methods
EP1812408B1 (en) 2004-11-02 2013-10-09 Northwestern University Pyridazine compounds, compositions and methods
EP2386554A1 (en) * 2005-07-04 2011-11-16 High Point Pharmaceuticals, LLC Compounds active at the histamine H3 receptor
RU2442775C2 (ru) * 2005-07-04 2012-02-20 Хай Пойнт Фармасьютикалс, ЛЛС Антагонисты гистаминовых н3-рецепторов
BRPI0710938A2 (pt) * 2006-04-28 2012-06-26 Univ Northwestern formulações contendo compostos de piridazina para o tratamento de doenças neuroinflamatórias
WO2007127448A2 (en) * 2006-04-28 2007-11-08 Northwestern University Salts of pyridazine compounds
WO2007127474A2 (en) 2006-04-28 2007-11-08 Northwestern University Compositions and treatments using pyridazine compounds and cholinesterase inhibitors
JP2009537596A (ja) 2006-05-23 2009-10-29 ハイ ポイント ファーマシューティカルズ,リミティド ライアビリティ カンパニー 6−(4−シクロプロピルピペリジン−1−イル)−2’−メチル−[3,4’]−ビピリジン及びその医薬としての使用
EP2079732B9 (en) 2006-05-29 2012-03-21 High Point Pharmaceuticals, LLC 3- (1, 3-benz0di0x0l-5-yl) -6- (4-cyclopropylpiperazin-1-yl) -pyridazine, its salts and solvates and its use as histamine h3 receptor antagonist
EP2014656A3 (en) 2007-06-11 2011-08-24 High Point Pharmaceuticals, LLC New heteocyclic h3 antagonists
US8461389B2 (en) 2008-04-18 2013-06-11 University College Dublin, National University Of Ireland, Dublin Psycho-pharmaceuticals
AR081331A1 (es) 2010-04-23 2012-08-08 Cytokinetics Inc Amino- pirimidinas composiciones de las mismas y metodos para el uso de los mismos
EP2560488B1 (en) 2010-04-23 2015-10-28 Cytokinetics, Inc. Certain amino-pyridines and amino-triazines, compositions thereof, and methods for their use
AR081626A1 (es) * 2010-04-23 2012-10-10 Cytokinetics Inc Compuestos amino-piridazinicos, composiciones farmaceuticas que los contienen y uso de los mismos para tratar trastornos musculares cardiacos y esqueleticos
WO2019145363A1 (en) 2018-01-23 2019-08-01 Institut Gustave-Roussy Use of minaprine to reduce tumor growth

Also Published As

Publication number Publication date
AU4350072A (en) 1973-12-20
FR2141697A1 (OSRAM) 1973-01-26
AR192370A1 (es) 1973-02-14
NL177893C (nl) 1985-12-16
US4169158A (en) 1979-09-25
JPS5550943B1 (OSRAM) 1980-12-20
SE392899B (sv) 1977-04-25
DE2229215A1 (de) 1973-01-25
CA1003833A (en) 1977-01-18
GB1345880A (en) 1974-02-06
NL177893B (nl) 1985-07-16
ES403998A1 (es) 1975-06-01
AU472247B2 (en) 1973-12-20
DE2229215C2 (de) 1984-09-06
FR2141697B1 (OSRAM) 1976-09-17
BE784727A (fr) 1972-10-02
NL7208355A (OSRAM) 1972-12-20

Similar Documents

Publication Publication Date Title
RO62435A (fr) Procede pour la preparation des 1,2,4-triazolenucleosides
RO71766A (ro) Procedeu pentru prepararea hexahidrodibenzo-(b,d)-piranilor
RO63727A (fr) Procede pour la preparation des 4-oxo-2h-1,2-benzothiazine-3-carboxamides
BE813990A (fr) Procede pour la preparation de 3-methylmercaptopropionaldehyde
BE812305A (fr) Procede pour la preparation de cyclohexanedione-1
RO70438A (ro) Procedeu pentru prepararea unor pirol-2-carboxamide substituite
RO62694A (fr) Procede pour la preparation des 3-methylencephalosporines
CH550805A (fr) Procede de preparation de nouveaux composes chimiques antiparasitaires.
RO62770A (fr) Procede pour la preparation des composes alcandieniques
RO63263A (fr) Procede pour la preparation des composes bicycliques
BE807434A (fr) Procede pour la preparation de 3,6-dihalo-diphenyl-alcanes
BE790181A (fr) Procede pour la preparation de trichloromethansulfenylchlorure
BE780171A (fr) Procede de preparation de nouveaux composes iodethinyles
CH548967A (fr) Procede pour la preparation de composes alicycliques oxygenes.
BE782935A (fr) Procede pour la preparation de composes tricycliques
CH549579A (fr) Procede pour la preparation de nouvelles hydroxy-pyrimidines.
CH548414A (fr) Procede de preparation de composes chimiques heterocycliques.
CH553178A (fr) Procede pour la preparation de la 3-hydroxy-2-alcoyl4-pyrone.
RO64595A (ro) Procedeu pentru prepararea compusilor 3-halogen-cefalosporine
RO68939A (ro) Procedeu pentru prepararea de izoxazolpirimidine substituite
BE783055A (fr) Procede pour la preparation de composes oxo
RO67345A (ro) Procedeu pentru prepararea 6-aza-1,2-dihioro-3b-1,4-benzodiazepinelor
RO69470A2 (fr) Procede pour la preparation des-5-pyrazolones -1- substitues
RO64143A (fr) Procede pour la preparation des 5-alkyle-5 aralcolxy-1,3-dioxanes
CH546731A (fr) Procede de preparation de composes phenyliques aubstitues.

Legal Events

Date Code Title Description
PUE Assignment

Owner name: C M INDUSTRIES

PUE Assignment

Owner name: SANOFI S.A.

PL Patent ceased